91 related articles for article (PubMed ID: 23902846)
1. [Effects of knocking down Gankyrin on breast cancer metastasis in mice].
Wang SX; Gong WL; Han QY; Man JH; Jin BF
Zhonghua Yi Xue Za Zhi; 2013 Apr; 93(14):1099-103. PubMed ID: 23902846
[TBL] [Abstract][Full Text] [Related]
2. Gankyrin promotes breast cancer cell metastasis by regulating Rac1 activity.
Zhen C; Chen L; Zhao Q; Liang B; Gu YX; Bai ZF; Wang K; Xu X; Han QY; Fang DF; Wang SX; Zhou T; Xia Q; Gong WL; Wang N; Li HY; Jin BF; Man JH
Oncogene; 2013 Jul; 32(29):3452-60. PubMed ID: 22890318
[TBL] [Abstract][Full Text] [Related]
3. Lidamycin up-regulates the expression of thymidine phosphorylase and enhances the effects of capecitabine on the growth and pulmonary metastases of murine breast carcinoma.
Zhang SH; Zhang H; He HW; Li L; Li XQ; Zhang YP; Shao RG
Cancer Chemother Pharmacol; 2013 Oct; 72(4):777-88. PubMed ID: 23975242
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of STAT3 expression by RNA interference inhibits the induction of breast tumors in immunocompetent mice.
Ling X; Arlinghaus RB
Cancer Res; 2005 Apr; 65(7):2532-6. PubMed ID: 15805244
[TBL] [Abstract][Full Text] [Related]
5. Gankyrin activates IL-8 to promote hepatic metastasis of colorectal cancer.
Bai Z; Tai Y; Li W; Zhen C; Gu W; Jian Z; Wang Q; Lin JE; Zhao Q; Gong W; Liang B; Wang C; Zhou T
Cancer Res; 2013 Jul; 73(14):4548-58. PubMed ID: 23576566
[TBL] [Abstract][Full Text] [Related]
6. [Effect of GTPase activating protein Git2 on metastasis in breast cancer].
Zhou W; Cao MG; Xu J; Fang ZY; Wang XY; Guo ZP; Li SS; Zhou ZH
Zhonghua Zhong Liu Za Zhi; 2016 Jul; 38(7):492-8. PubMed ID: 27531261
[TBL] [Abstract][Full Text] [Related]
7. Gankyrin is essential for hypoxia enhanced metastatic potential in breast cancer cells.
Gao L; Xie H; Dong L; Zou J; Fu J; Gao X; Ou L; Xiang S; Song H
Mol Med Rep; 2014 Mar; 9(3):1032-6. PubMed ID: 24337075
[TBL] [Abstract][Full Text] [Related]
8. The serine protease inhibitor protease nexin-1 controls mammary cancer metastasis through LRP-1-mediated MMP-9 expression.
Fayard B; Bianchi F; Dey J; Moreno E; Djaffer S; Hynes NE; Monard D
Cancer Res; 2009 Jul; 69(14):5690-8. PubMed ID: 19584287
[TBL] [Abstract][Full Text] [Related]
9. Association of gankyrin protein expression with early clinical stages and insulin-like growth factor-binding protein 5 expression in human hepatocellular carcinoma.
Umemura A; Itoh Y; Itoh K; Yamaguchi K; Nakajima T; Higashitsuji H; Onoue H; Fukumoto M; Okanoue T; Fujita J
Hepatology; 2008 Feb; 47(2):493-502. PubMed ID: 18161051
[TBL] [Abstract][Full Text] [Related]
10. Gankyrin-mediated dedifferentiation facilitates the tumorigenicity of rat hepatocytes and hepatoma cells.
Sun W; Ding J; Wu K; Ning BF; Wen W; Sun HY; Han T; Huang L; Dong LW; Yang W; Deng X; Li Z; Wu MC; Feng GS; Xie WF; Wang HY
Hepatology; 2011 Oct; 54(4):1259-72. PubMed ID: 21735473
[TBL] [Abstract][Full Text] [Related]
11. Gankyrin is frequently overexpressed in breast cancer and is associated with ErbB2 expression.
Kim YH; Kim JH; Choi YW; Lim SK; Yim H; Kang SY; Chung YS; Lee GY; Park TJ
Exp Mol Pathol; 2013 Apr; 94(2):360-5. PubMed ID: 23276718
[TBL] [Abstract][Full Text] [Related]
12. Gankyrin promotes the proliferation of human pancreatic cancer.
Meng Y; He L; Guo X; Tang S; Zhao X; Du R; Jin J; Bi Q; Li H; Nie Y; Liu J; Fan D
Cancer Lett; 2010 Nov; 297(1):9-17. PubMed ID: 20483533
[TBL] [Abstract][Full Text] [Related]
13. Bcl-2/adenovirus E1B 19 kDa interacting protein-3 knockdown enables growth of breast cancer metastases in the lung, liver, and bone.
Manka D; Spicer Z; Millhorn DE
Cancer Res; 2005 Dec; 65(24):11689-93. PubMed ID: 16357180
[TBL] [Abstract][Full Text] [Related]
14. Microenvironment of the murine mammary carcinoma 4T1: endogenous IFN-gamma affects tumor phenotype, growth, and metastasis.
duPre' SA; Redelman D; Hunter KW
Exp Mol Pathol; 2008 Dec; 85(3):174-88. PubMed ID: 18929358
[TBL] [Abstract][Full Text] [Related]
15. Grape seed proanthocyanidins induce apoptosis and inhibit metastasis of highly metastatic breast carcinoma cells.
Mantena SK; Baliga MS; Katiyar SK
Carcinogenesis; 2006 Aug; 27(8):1682-91. PubMed ID: 16597645
[TBL] [Abstract][Full Text] [Related]
16. Effect of Smad7 expression on metastasis of mouse mammary carcinoma JygMC(A) cells.
Azuma H; Ehata S; Miyazaki H; Watabe T; Maruyama O; Imamura T; Sakamoto T; Kiyama S; Kiyama Y; Ubai T; Inamoto T; Takahara S; Itoh Y; Otsuki Y; Katsuoka Y; Miyazono K; Horie S
J Natl Cancer Inst; 2005 Dec; 97(23):1734-46. PubMed ID: 16333029
[TBL] [Abstract][Full Text] [Related]
17. Upregulated IL-19 in breast cancer promotes tumor progression and affects clinical outcome.
Hsing CH; Cheng HC; Hsu YH; Chan CH; Yeh CH; Li CF; Chang MS
Clin Cancer Res; 2012 Feb; 18(3):713-25. PubMed ID: 22186257
[TBL] [Abstract][Full Text] [Related]
18. Intrinsic focal adhesion kinase activity controls orthotopic breast carcinoma metastasis via the regulation of urokinase plasminogen activator expression in a syngeneic tumor model.
Mitra SK; Lim ST; Chi A; Schlaepfer DD
Oncogene; 2006 Jul; 25(32):4429-40. PubMed ID: 16547501
[TBL] [Abstract][Full Text] [Related]
19. Targeting fibroblast growth factor receptors blocks PI3K/AKT signaling, induces apoptosis, and impairs mammary tumor outgrowth and metastasis.
Dey JH; Bianchi F; Voshol J; Bonenfant D; Oakeley EJ; Hynes NE
Cancer Res; 2010 May; 70(10):4151-62. PubMed ID: 20460524
[TBL] [Abstract][Full Text] [Related]
20. Multimodality imaging of IL-18--binding protein-Fc therapy of experimental lung metastasis.
Cao Q; Cai W; Niu G; He L; Chen X
Clin Cancer Res; 2008 Oct; 14(19):6137-45. PubMed ID: 18829492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]